Navigation Links
KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results
Date:8/11/2008

of the Company's products, as well as new product launches planned during fiscal 2009 and their potential impact on fiscal 2009 financial performance, we are providing guidance for the current fiscal year. It is not the Company's expectation to further update this guidance during the course of the fiscal year or for future periods.

Subsequent Event

The Company was notified last week that the Audit Committee of its Board of Directors has recently commenced an independent inquiry into allegations made by sources not identified to management regarding alleged misconduct by management of the Company. Since 1995, the Company has had in place a Standard of Business Ethics Policy. As part of this policy, an employee is encouraged to report, independent of management and for any reason, any action an employee suspects to be contrary to this code of ethics. Management has not been advised as to the specifics of the allegations and is not in a position to make an informed determination as to whether the allegations have any merit. Management is not aware of and does not believe that there has been any misconduct that would have a material impact on the Company's financial results. Management is cooperating fully with the Committee.

As a result of the inquiry, KPMG LLP, the Company's independent registered public accounting firm, has advised the Company that they will be unable to complete its SAS 100 review of the consolidated financial statements for the first quarter of fiscal 2009, prior to reviewing the results of the completed Audit Committee inquiry.

About Evamist(TM)

Evamist(TM), the first and only estradiol transdermal spray, delivers a low dose of plant-based estradiol and provides convenient relief of moderate-to-severe vasomotor symptoms, reducing both the frequency and severity of hot flashes. Evamist(TM) utilizes metered-dose technology to deliver a consistent and accurate dose of estradiol when sprayed on the inner forearm, dr
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008).... 21 The general membership of the... three new individuals at their Annual,Awards Din...el in New York. A,Lifetime Achievement Award will...he Medical Advertising Hall of Fame are: , Rona... an account position,at Sudler & Hennessey. I...
(Date:11/21/2008)..., a new and deadly diseaseits cause remains a myst...was teeming with citizens, soldiers and refugees o...s streets filled with corpses, social order broke ...ned twice and Athens lost a third of its populatio...d the beginning of the end of the Golden Age of Gr...
(Date:11/21/2008)...21 Innerscope Research(TM), a revo...ing in Emotional Response Measurement,announced ... strengthen the,company,s research and developmen..., The three appointments, who deliver a comb...l as Chief Financial Officer and Vice President of...
(Date:11/21/2008)...., Nov. 21 Gilbert Hosp... industry, has initiated a new customer service ca...ds for Service; Mission; Ideals; Leadership; Excel...Donna Ritchie of Inpatient Services and Carolyn Ma...velopment of the S.M.I.L.E. campaign came to life ...
Breaking Medicine News(10 mins):Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:Gilbert Hospital Kicks Off New Customer Service S.M.I.L.E. Campaign 2
...at drinking one or two glasses of alcohol helps in...cohol has no such effect//. Dr Rod Jackson and col...dy and challenged the French paradox that makes be...alth and longevity of French population. They term...
...y brings joy and excitement to the parents and fam...ith joy following the birth of baby Maia, after he...atment a relapse of Hodgkin’s lymphoma. She would ... and self. This time, the cancer turned out to b...
...med at preventing amputations and other disease-re...at a remote village in India’s State of Tamil Nadu...nts who visited the "Diabetes Amputation Preventio...rogramme at Maragal Kandigai village out of mere c...
...arthquake relief camp is further complicating the ...at Muzaffarabad. As many as 14 cases have been rep...la Camp//. "All of them are children and under su...ik, Pakistan occupied Kashmir's Secretary of Healt...
Other Medicine News:Health News:Robotic ovarian transposition helps cancer patient deliver baby 2
(Date:11/20/2008)...ember 20 The Scandinavian-based dr...ced results of studies on its,lead antimicrobial ...n, DC,the studies showed that the novel lytic pe...ect, significantly better towards killing Staphylo...keted gold standard drugs. In,addition to this it...
(Date:11/19/2008)...ort basic findings on critical enzyme,s regulation... an array of disorders , , MEMPHIS, Tenn., ...St. Jude Children,s Research Hospital have gained ...enzyme workhorses called calpains. , , As ...ion in many cellular processes, including the move...
(Date:11/18/2008)...Newswire-FirstCall/ -- NeuroDiscovery Ltd (ASX:,N... drug development Company,and Sosei Group Corpor...g,international biopharmaceutical company, today ...r pivotal pre-clinical efficacy data for NSL-043/S...erapy for neuropathic pain and has,successfully c...
(Date:11/18/2008)...on,s 2008 Faces of Influenza survey underscores th...influenza; Mother and Gold Medalist Kristi Yamaguc...8 While 78 percent of mothers in t...otentially life-threatening disease that can strik...s will get vaccinated this season, according to a ...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results 11118 1Barr Launches Generic Fosamax 28R 29 Tablets 70 mg 3067 1Barr Launches Generic Fosamax 28R 29 Tablets 70 mg 3067 2Barr Launches Generic Fosamax 28R 29 Tablets 70 mg 3067 3Barr Launches Generic Fosamax 28R 29 Tablets 70 mg 3067 4Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension 11113 1Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension 11113 2SpringCM Improves Contract Management Efficiency for Medical Staffing Agency 11109 1SpringCM Improves Contract Management Efficiency for Medical Staffing Agency 11109 2SpringCM Improves Contract Management Efficiency for Medical Staffing Agency 11109 3
...ss.--(BUSINESS WIRE)--May 7, 2007 - OXiGENE, Inc.,...chnology company,developing novel therapeutics to ...t the results of its Phase II combretastatin A4,ph...generation,(MMD) was presented at the 47th Annual ...nd Ophthalmology (ARVO) in Fort Lauderdale,FL. Th...
...SCO, May 07, 2007 /PRNewswire/ -- Interim results ...ney-sparing treatment,protocol using CellCept(R) (...can Transplant Congress. This and other Spare the,...t recipients,examine ways to prevent rejection wit...e living longer, doctors are finding,that older th...
Other Medicine Technology:OXiGENE Announces a Poster Presentation Highlighting Results from,its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study,MMD-213) at the 47th Annual Meeting of the Association of Research,in Vision and Ophthalmology 2OXiGENE Announces a Poster Presentation Highlighting Results from,its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study,MMD-213) at the 47th Annual Meeting of the Association of Research,in Vision and Ophthalmology 3Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 2Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 3Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 4Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 5
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option.
300XL System, English (U.K. cord), 100-240 VAC.
Micro-mini fiber optic light.
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light.
Medicine Products: